Ssi Investment Management LLC Biogen Inc. Transaction History

Ssi Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $161,304 - $210,358	-570 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $147,630 - $236,384	570 New	570 $200,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $177,683 - $225,054	-638 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $187,259 - $244,883	638 New	638 $223,000
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $193,655 - $230,796	-752 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $3,381 - $4,782	-13 Reduced 1.7%	752 $206,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $215,079 - $252,212	765	765 $0

1,049

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ssi Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ssi Investment Management LLC with notifications on news.